Google DeepMind has grand ambitions to 'cure all diseases' with AI. Now, it's gearing up for its first human trials
There are people sitting in our office in King's Cross, London, working, and collaborating with AI to design drugs for cancer. That's happening right now.
Luxembourg's Exobiosphere raises 2M to accelerate drug discovery in space; here's why and how - Silicon Canals
Luxembourg-based Exobiosphere has raised â¬2M for its mission to redefine drug discovery in space using autonomous, standardised lab automation to improve efficacy.